Protective effect of Ssanghwa-tang fermented by Lactobacillus fermentum against carbon tetrachloride-induced acute hepatotoxicity in rats.

Ssanghwa-tang (SHT) is a traditional herbal medicine formula that has been used for the development of physical strength, relief of pain, and the reduction of fatigue. In this study, we fermented SHT with Lactobacillus fermentum (L. fermentum), Lactobacillus gasseri (L.gasseri), or Lactobacillus casei (L.casei) to investigate the hepatoprotective effects of SHT and fermented SHT with Lactobacillus on carbon tetrachloride (CCl(4))-induced liver injury in rats. Rats were given CCl(4) (1 ml/kg, 50% CCl(4) in olive oil) intraperitoneally and either SHT or fermented SHTs (15 ml/kg) was administered 30 min before CCl(4). At 24 hr after CCl(4) injection, the levels of transaminases in the serum were markedly increased. These increases were significantly attenuated by either SHT + L. fermentum or SHT+ L.gasseri. However, SHT and SHT + L.casei showed slight suppression of the increase of transaminases. The liver histological changes were diminished by treatment with SHT + L. fermentum. Additionally, the potential hepatoprotective effect of fermented-SHTs correlated with the amount of unknown metabolite which is produced during fermentation process with L. fermentum, L.gasseri, or L.casei. Therefore, these results suggest that the hepatoprotective effect of SHT may be improved by fermentation with L. fermentum and the intestinal bacterial enzyme activities may likely play an important role in the pharmacological action of herbal medicines.

[1]  D. Kim,et al.  Metabolism of kalopanaxsaponin B and H by human intestinal bacteria and antidiabetic activity of their metabolites. , 1998, Biological & pharmaceutical bulletin.

[2]  O. Al‐Shabanah,et al.  Protective effect of aminoguanidine, a nitric oxide synthase inhibitor, against carbon tetrachloride induced hepatotoxicity in mice. , 1999, Life sciences.

[3]  S. Barnes,et al.  Genistein, daidzein, and their .beta.-glycoside conjugates: antitumor isoflavones in soybean foods from American and Asian diets , 1993 .

[4]  R. Padmanabhan,et al.  Clinical Safety of Lactobacillus casei shirota as a Probiotic in Critically Ill Children , 2006, Journal of pediatric gastroenterology and nutrition.

[5]  R Yuan,et al.  Traditional Chinese medicine: an approach to scientific proof and clinical validation. , 2000, Pharmacology & therapeutics.

[6]  D. J. Kim,et al.  Safety Assessment of Lactobacillus fermentum PL9005, a Potential Probiotic Lactic Acid Bacterium, in Mice , 2005 .

[7]  K. Setchell,et al.  Dietary isoflavones: biological effects and relevance to human health. , 1999, The Journal of nutrition.

[8]  Junxian He,et al.  Restorative effect of repetitive administration of Shaoyao-Gancao-tang on bioavailability of paeoniflorin reduced by antibacterial synthetic drugs treatment in rats. , 2003, Biological & pharmaceutical bulletin.

[9]  K. Kobashi,et al.  Relation of Intestinal Bacteria to Pharmacological Effects of Glycosides , 1997 .

[10]  K. Wen,et al.  A deglucosylated metabolite of paeoniflorin of the root of Paeonia lactiflora and its pharmacokinetics in rats. , 2003, Planta medica.

[11]  J. H. Martin,et al.  The effect of prebiotics on production of antimicrobial compounds, resistance to growth at low pH and in the presence of bile, and adhesion of probiotic cells to intestinal mucus , 2006, Journal of applied microbiology.

[12]  M. Hattori,et al.  Pharmacokinetic study of paeonimetabolin I, a major metabolite of paeoniflorin from paeony roots. , 1997, Biological & pharmaceutical bulletin.

[13]  T. Klaenhammer,et al.  Selection and design of probiotics. , 1999, International journal of food microbiology.

[14]  K. M. Madyastha,et al.  C-phycocyanin: a potent peroxyl radical scavenger in vivo and in vitro. , 2000, Biochemical and biophysical research communications.

[15]  J. Malago,et al.  Inhibition of Salmonella-induced IL-8 synthesis and expression of Hsp70 in enterocyte-like Caco-2 cells after exposure to non-starter lactobacilli. , 2006, International journal of food microbiology.

[16]  S. Amagaya,et al.  Absorption and Excretion of Paeoniflorin in Rats , 1995, The Journal of pharmacy and pharmacology.

[17]  M. Nair,et al.  Metabolism of daidzein and genistein by intestinal bacteria. , 1995, Journal of natural products.

[18]  N. Shah,et al.  Development of an isoflavone aglycone-enriched soymilk using soy germ, soy protein isolate and bifidobacteria , 2004 .

[19]  Tung-Ching Lee,et al.  Enrichment of bioactive isoflavones in soymilk fermented with β-glucosidase-producing lactic acid bacteria , 2005 .

[20]  M. Athar,et al.  Drug Metabolizing Enzymes in the Liver , 1997 .

[21]  J. Castro,et al.  Diverse effects of SKF 525-A and antioxidants on carbon tetrachloride-induced changes in liver microsomal P-450 content and ethylmorphine metabolism. , 1968, Life sciences.

[22]  A. Darfeuille‐Michaud,et al.  Lactobacillus casei DN-114 001 Inhibits the Ability of Adherent-Invasive Escherichia coli Isolated from Crohn's Disease Patients To Adhere to and To Invade Intestinal Epithelial Cells , 2005, Applied and Environmental Microbiology.

[23]  Y. Benno,et al.  Role of Human Intestinal Prevotella oris in Hydrolyzing Ginseng Saponins , 1997, Planta medica.

[24]  J. López-Novoa,et al.  A micropuncture study of salt and water retention in chronic experimental cirrhosis. , 1977, The American journal of physiology.

[25]  W. Lu,et al.  Determination of an economical medium for growth of Lactobacillus fermentum using response surface methodology , 2009, Letters in applied microbiology.

[26]  M. Choo,et al.  Antithrombotic and antiallergic activities of rhaponticin from rhei rhizoma are activated by human intestinal bacteria , 2002, Archives of pharmacal research.

[27]  C. Shim,et al.  Effects of a blended Korean herbal remedy, Ssang Wha Tang, on the liver cytoplasmic protein binding of sulfobromophthalein in rats , 1989 .

[28]  Ki-Ho Cho,et al.  Fecal metabolic activities of herbal components to bioactive compounds , 2002, Archives of pharmacal research.

[29]  T. Koivula,et al.  A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. , 1991, Pediatrics.

[30]  Teruaki Akao,et al.  Isoliquiritigenin, one of the antispasmodic principles of Glycyrrhiza ularensis roots, acts in the lower part of intestine. , 2007, Biological & pharmaceutical bulletin.

[31]  R. Pérez Tamayo.  Is cirrhosis of the liver experimentally produced by CCl4 and adequate model of human cirrhosis? , 1983, Hepatology.

[32]  R. Ohba,et al.  Solubilization of a novel isoflavone glycoside-hydrolyzing β-glucosidase from Lactobacillus casei subsp. rhamnosus , 1994 .

[33]  R. P. Tamayo.  Is Cirrhosis of the Liver Experimentally Produced by CC14 an Adequate Model of Human Cirrhosis? , 2007 .

[34]  S. Shott,et al.  Defense factors of vaginal lactobacilli. , 2001, American journal of obstetrics and gynecology.